tbResList Print — CUSP9 CUSP9

Filters: qv=296, qv2=%, rfv=%

Product

CUSP9 CUSP9
Description: <b>CUSP9 </b>coordinated undermining of survival paths with nine repurposed drugs<br>
-includes aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, sertraline, ritonavir<br>

Pathway results for Effect on Cancer / Diseased Cells

Drug Metabolism & Resistance

Dose↝, 2,  

Functional Outcomes

QoL↑, 1,  
Total Targets: 2

Pathway results for Effect on Normal Cells

Total Targets: 0

Research papers

Year Title Authors PMID Link Flag
2013A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma CareRichard E KasPMC3720600https://pmc.ncbi.nlm.nih.gov/articles/PMC3720600/0